论文部分内容阅读
目的:评价雷帕霉素洗脱支架(CypherTM)的安全性及近期有效性。方法:回顾性分析212例接受CypherTM置入术患者的即刻疗效和临床随访结果。结果:212例患者共处理病变289处,置入支架377枚,其中225处病变置入246枚CypherTM。2处严重钙化病变需辅以高压球囊才充分扩张,2例未能通过病变处,1处支架近端发生内膜撕裂,其余全部成功置入。手术过程及住院期间无严重并发症发生,成功率98.6%。197例患者平均随访3~12(7.4±3.0)个月,无心肌梗死发生,1例猝死,16例患者心绞痛再发,其中7例为普通金属支架内的再狭窄,8例为其他分支的新病变,1例CypherTM内近端再狭窄。212例患者中共38例复查了冠状动脉造影,1例CypherTM内再狭窄。结论:CypherTM近期安全有效。
OBJECTIVE: To evaluate the safety and near-term efficacy of the rapamycin-eluting stent (CypherTM). Methods: A retrospective analysis of 212 patients treated with CypherTM immediate effect and clinical follow-up results. Results: A total of 212 lesions were treated with 289 lesions and 377 scaffolds, of which 246 CypherTM were placed in 225 lesions. Serious calcification of 2 lesions required by the high-pressure balloon was fully expanded, 2 cases failed to pass the lesion, a proximal stent intimal tear, the rest all the successful placement. During the operation and hospitalization without serious complications, the success rate was 98.6%. 197 patients were followed up for an average of 3 to 12 months (7.4 ± 3.0) months without myocardial infarction, 1 case of sudden death and 16 cases of recurrent angina pectoris. Among them, 7 cases were restenosis in general metal stent and 8 cases were in other branches New lesions, 1 case of proximal proximal restenosis CypherTM. Among 212 patients, 38 patients underwent coronary angiography and 1 CypherTM internal restenosis. Conclusion: CypherTM is safe and effective recently.